Risk factors and outcomes of bloodstream infections with metallo-β-lactamase-producing Acinetobacter-Reference-Cited by-同舟云学术

Risk factors and outcomes of bloodstream infections with metallo-β-lactamase-producing Acinetobacter

Published:2008-01 Issue:3 Volume:40 Page:234-240
ISSN:0036-5548
Container-title:Scandinavian Journal of Infectious Diseases
language:en
Short-container-title:Scandinavian Journal of Infectious Diseases

Author:

Kim Yeon-a,Yong choi Jun,Ki kim Chang,Oh kim Chang,Soo kim Myung,Hoon choi Suk,Sik chin Bum,Hoon han Sang,Sung lee Han,Kyoung choi Hee,Jin jeoung Su,Goo song Young,Hwa yum Jong,Yong Dongeun,Lee Kyungwon,Myung kim June

Publisher

Informa UK Limited

Subject

Infectious Diseases,Microbiology (medical),General Immunology and Microbiology,General Medicine

Link

http://www.tandfonline.com/doi/pdf/10.1080/00365540701633004

Reference26 articles.

1. Geographic variations in activity of broad-spectrum β-lactams against Pseudomonas aeruginosa: summary of the worldwide SENTRY Antimicrobial Surveillance Program (1997–2000)

2. MYSTIC (Meropenem Yearly Susceptibility Test Information Collection) results from the Americas: resistance implications in the treatment of serious infections

3. A novel integron-like element carrying the metallo-beta-lactamase gene blaIMP

4. Metallo-β-Lactamases in Clinical Pseudomonas Isolates in Taiwan and Identification of VIM-3, a Novel Variant of the VIM-2 Enzyme

5. Cloning and Characterization of bla VIM , a New Integron-Borne Metallo-β-Lactamase Gene from a Pseudomonas aeruginosa Clinical Isolate

Cited by 23 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Lipocalin-2 is an essential component of the innate immune response to Acinetobacter baumannii infection;PLOS Pathogens;2022-09-02

2. Bloodstream infections in adult patients with malignancy, epidemiology, microbiology, and risk factors associated with mortality and multi-drug resistance;BMC Infectious Diseases;2021-07-02

3. Importance of control groups when delineating antibiotic use as a risk factor for carbapenem resistance, extreme-drug resistance, and pan-drug resistance in Acinetobacter baumannii and Pseudomonas aeruginosa: A systematic review and meta-analysis;International Journal of Infectious Diseases;2018-11

4. Exploring the resistance mechanism of imipenem in carbapenem hydrolysing class D beta-lactamases OXA-143 and its variant OXA-231 (D224A) expressing Acinetobacter baumannii: An in-silico approach;Computational Biology and Chemistry;2017-04

5. Global prevalence of carbapenem resistance in neutropenic patients and association with mortality and carbapenem use: systematic review and meta-analysis;Journal of Antimicrobial Chemotherapy;2016-12-20